Impact of Vancomycin-Resistant <i>Enterococci</i> (VRE)–Active Perioperative Prophylaxis in Liver Transplant Patients Colonized by VRE
Giulia Burastero(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Erica Franceschini(University of Modena and Reggio Emilia), Fabrizio Di Benedetto(University of Modena and Reggio Emilia), Davide Lo Porto(Istituti di Ricovero e Cura a Carattere Scientifico), Giacomo Assirati(University of Modena and Reggio Emilia), Adriana Cervo(Azienda Ospedaliero-Universitaria di Modena), Salvatore Gruttadauria, Alessandra Mularoni(Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Emmanuel Wey(Royal Free London NHS Foundation Trust), Marianna Meschiari(Azienda Ospedaliero-Universitaria di Modena), Cristina Mussini(University of Modena and Reggio Emilia), Veronica Guidetti(University of Modena and Reggio Emilia), Samuele Cantergiani(Azienda Ospedaliero-Universitaria di Modena), Andrea Cona(Istituti di Ricovero e Cura a Carattere Scientifico), Valentina Menozzi(University of Modena and Reggio Emilia), Amreen Khan(The Royal Free Hospital), Giovanni Dolci(University of Modena and Reggio Emilia), Valentina Serra(University of Modena and Reggio Emilia), Giovanni Guaraldi(University of Modena and Reggio Emilia), Joerg-Matthias Pollok(Royal Free London NHS Foundation Trust), Martina Tosi(Ospedale Papa Giovanni XXIII)
Cited by 7
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
|Clinical Infectious Diseases|2011|1.3k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
|Clinical Infectious Diseases|2018|424